Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Health Catalyst, Inc - Common stock (NQ:HCAT)

4.050 +0.280 (+7.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Health Catalyst, Inc - Common stock

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst
Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating... 
Via Benzinga
Veeva Systems Stock Scores Rising Relative Strength Rating
The Relative Strength (RS) Rating for Veeva Systems stock climbed into a higher percentile Thursday, as it got a lift from 67 to 72. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
Via Benzinga
7 Analysts Have This to Say About Health Catalyst
Via Benzinga
Analyst Expectations for Health Catalyst's Future
Via Benzinga
Expert Ratings for Health Catalyst
Via Benzinga
What 6 Analyst Ratings Have To Say About Health Catalyst
Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Health Catalyst's Q1 Earnings: Analysts Diverge on Outlook as Company Faces Demand Headwinds and Revenue Outperformance
Health Catalyst Inc (NASDAQ: HCAT) reported Q1 sales of $73.87 million, up 22% Y/Y, beating the consensus of $71.24 million< 
Via Benzinga
Nasdaq, S&P 500 Higher As Bond Yields Retreat
Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Via Benzinga
Why Health Catalyst Stock Rallied Wednesday Morning
The data analytics specialist delivered results that weren't as bad as investors had feared. 
Via The Motley Fool
Why Shares of Health Catalyst Popped 23.34% on Wednesday
The company continued its upward trend in revenue growth. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
Via Benzinga
3 Top Tech Stocks That Could Help Make You Rich by Retirement
These companies are raining down revenue from cloud computing. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Via Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
Via Benzinga
Analyst Ratings for Health Catalyst
Over the past 3 months, 6 analysts have published their opinion on Health Catalyst (NASDAQ:HCAT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
US Stocks Open Lower; Dow Drops 250 Points
U.S. stocks traded lower this morning as investors focused on the outcome of the midterm elections, with the Dow Jones dropping around 250 points on Wednesday. 
Via Benzinga
Earnings Preview For Health Catalyst
Health Catalyst (NASDAQ:HCAT) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Health... 
Via Benzinga
7 Analysts Have This to Say About Health Catalyst
Over the past 3 months, 7 analysts have published their opinion on Health Catalyst (NASDAQ:HCAT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022
Upgrades 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 120 companies set new 52-week lows. 
Via Benzinga
Costco's Price Target Cut By This Analyst? Plus Citigroup Sees $91 For Wynn Resorts
Raymond James cut the price target on Costco Wholesale Corporation (NASDAQ: COST) from $600 to $560. Raymond James analyst Bobby Griffin maintained an Outperform rating on the stock. Costco shares rose... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.